Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema

To predict the need for additional local corticosteroids after receiving the 0.19 mg fluocinolone acetonide (FAc) implant in patients with macular edema secondary to non-infectious uveitis previously treated with local peribulbar corticosteroids. The number of corticosteroids required prior FAc, vis...

Descripción completa

Detalles Bibliográficos
Autores principales: Kessler, Lucy Joanne, Łabuz, Grzegorz, Auffarth, Gerd U., Khoramnia, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028038/
https://www.ncbi.nlm.nih.gov/pubmed/35456522
http://dx.doi.org/10.3390/pharmaceutics14040688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028038/
https://www.ncbi.nlm.nih.gov/pubmed/35456522
http://dx.doi.org/10.3390/pharmaceutics14040688

Ejemplares similares